Aryl hydrocarbon receptor signaling in osteosarcopenia: an integrative framework for musculoskeletal aging
Biochimie · 2026-09 · 248 · 84-91
DOI: 10.1016/j.biochi.2026.02.016 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimie, 2026-09. Verfasst von Hassan Rammal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Bone, Muscle & Geroscience Group, Research Institute of the McGill University Health Centre, Montreal, QC, H4A 3J1, Canada; Division of Geriatric Med…. Hauptthemen laut MEDLINE: Receptors, Aryl Hydrocarbon, Signal Transduction, Aging, Sarcopenia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aging is accompanied by a progressive decline in tissue integrity and functional capacity and is a major risk factor for chronic disease. Osteosarcopenia, defined as the concurrent loss of bone and skeletal muscle mass and function, is a major contributor to frailty, fractures, disability, and reduced quality of life in older adults. While musculoskeletal aging has traditionally been attributed to endocrine and mechanical factors, growing evidence highlights an important role for environmental, microbial, and dietary signals in influencing tissue homeostasis across the lifespan. The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that integrates these diverse cues and has emerged as a critical regulator of musculoskeletal homeostasis. In this review, we examine the emerging role of AhR signaling in the regulation of bone and skeletal muscle biology and discuss how context-dependent AhR signaling contributes to key hallmarks of aging, including oxidative stress, mitochondrial dysfunction, chronic inflammation, altered tryptophan metabolism, and gut dysbiosis. We propose that sustained or dysregulated AhR activation provides a mechanistic link between aging-related systemic stressors and the development of osteosarcopenia, highlighting AhR signaling as a potential target for preserving musculoskeletal health during aging. • AhR signaling links environmental cues to bone and muscle decline • Dysregulated AhR promotes inflammation and mitochondrial dysfunction • Dysregulated AhR alters osteoblast and myocyte differentiation pathways • Crosstalk with microbiome and toxins accelerates osteosarcopenia • Targeting AhR offers therapeutic and precision aging strategies
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bone, Muscle & Geroscience Group, Research Institute of the McGill University Health Centre, Montreal, QC, H4A 3J1, Canada; Division of Geriatric Medicine, Department of Medicine, McGill University, Montreal, QC, H3A 2B…
- Bone, Muscle & Geroscience Group, Research Institute of the McGill University Health Centre, Montreal, QC, H4A 3J1, Canada.
Zitieren
APA
Rammal, H., Noonan, A. M., Rivas, D., Sibai, D. S., Marcangeli, V., & Duque, G. (2026). Aryl hydrocarbon receptor signaling in osteosarcopenia: an integrative framework for musculoskeletal aging. Biochimie, 248, 84-91. https://doi.org/10.1016/j.biochi.2026.02.016
Vancouver
Rammal H, Noonan AM, Rivas D, Sibai DS, Marcangeli V, Duque G. Aryl hydrocarbon receptor signaling in osteosarcopenia: an integrative framework for musculoskeletal aging. Biochimie. 2026;248:84-91. doi:10.1016/j.biochi.2026.02.016
BibTeX
@article{Rammal2026,
author = {Rammal, Hassan and Noonan, Alex M and Rivas, Daniel and Sibai, Dany S and Marcangeli, Vincent and Duque, Gustavo},
title = {Aryl hydrocarbon receptor signaling in osteosarcopenia: an integrative framework for musculoskeletal aging},
journal = {Biochimie},
year = {2026},
volume = {248},
pages = {84--91},
doi = {10.1016/j.biochi.2026.02.016}
}
EUVIMED